Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. - Wikidata - awgldk - TriplyDB

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

http://www.wikidata.org/entity/Q42112516

about

Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Nanoparticle-Based Antimicrobials: Surface Functionality is Critical Computational design of an endo-1,4- -xylanase ligand binding site Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Host-guest chemistry of the peptidoglycan Deciphering the magainin resistance process of Escherichia coli strains in light of the cytosolic proteome Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Mechanisms of antibiotic resistance in Staphylococcus aureus.Multivalent artificial opsonin for the recognition and phagocytosis of Gram-positive bacteria by human phagocytes.Genetics of antimicrobial resistance in Staphylococcus aureus.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus.Heat stable antimicrobial activity of Burkholderia gladioli OR1 against clinical drug resistant isolates Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis.First report of vancomycin-intermediate resistance in sequence type 72 community genotype methicillin-resistant Staphylococcus aureus.Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.Generation of ramoplanin-resistant Staphylococcus aureus.Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus.Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.Intermediate vancomycin susceptibility in a community-associated MRSA clone.Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3 Diagnosis and management of community-associated MRSA infections in children.Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.

P2860

Q24490083-4A589D50-2DA2-41C8-A2C7-F9AB9FEADAEE Q24646677-7F47E6B6-9CDD-4A8B-9C82-18D73F312DD8 Q26752437-E974CC96-170A-4D78-81C7-3BE1B35237CB Q27667054-8E5B238B-1B49-4149-AA56-47A850AD9F5F Q28078930-A77372E3-AC94-42F2-A0B7-769DBB66ADA3 Q33264418-1F200CCA-032A-429D-A6AB-6ED84869678B Q33321447-51701552-4405-4531-AE86-1DA7C3411354 Q34013593-B9D68328-CCA2-4662-95FD-9413938265D7 Q34145463-5DF70724-7EFF-46C0-8EA3-7EAC2BC1C0D7 Q34522708-BA0E520C-8AB1-4373-969C-461902BD80AD Q34632683-40F3FD7E-FAD0-499A-807A-B4997A2B599B Q34648042-9D3ED019-4699-489F-AFD2-59CB473354C3 Q34657311-6652A55A-B6C9-46B6-AAA3-3A922D27C860 Q34754245-7CCEC9E7-C405-471D-ADBD-0EF875118B5A Q34984662-09642BAE-4B06-4468-B782-629CCF2A8B60 Q35023285-A4D1ABCD-EBF4-4650-AD02-7F953E99ECA2 Q35023343-282B4CA8-85D7-4530-B68D-DB1927BA5D10 Q35635966-E7E290D0-14F2-4BAB-811B-59D1B7FCF009 Q35666429-6406B6EB-69D1-466B-A02C-39B293037E8F Q35691679-E18BD41D-BF16-4D50-8E4C-28EE925A1D63 Q36095036-BE4AB982-8700-4F0B-9C56-F7C423CD4EC5 Q36107639-1ADBE471-A63F-4D64-B191-1E83ED70794A Q36111786-EE2EDA5A-43D8-44C0-88B6-C4D244FF7C52 Q36118613-CCC51F9F-E7FC-4DC1-9157-12A74D2CC5FD Q36155088-8F7D7C7E-3E83-43EF-A110-51A30EE6A16A Q36538634-7C626CF1-6436-4CCB-8E68-3BA1183F3B3C Q36680162-F85A34C9-D048-4C75-985F-2CDCD62C9760 Q36758570-07E1BA33-1007-4202-9A76-E8D0459CD896 Q36805214-8594F6EA-C5BA-416F-BF9C-B33C3AC4E5F4 Q36903680-3B8CA5E4-CD4C-4EDE-B775-EA30DD7A10C0 Q36910633-E50DE0C0-91D7-41C4-BA91-1EBDB4B230E0 Q36964857-437D4D44-DBA1-48F2-9476-1BBA819F778C Q37026697-808DE8DF-97B4-4898-8D36-AF2E0F4A3E6C Q37243126-BDB63A90-181E-43D0-A916-2ED67DB12A41 Q37274745-19CB3384-6E45-4746-947D-5FC2ECC50202 Q37302793-2EF6A185-0EB1-4FA4-BB5A-65A2EA8A64CA Q37335734-6829FEA2-123B-4986-B03A-A5DED079B0FD Q37682916-558B227C-955A-4B0B-987F-A49E0A577B44 Q37717901-C5F0ADE1-4C70-46AB-AC30-67F56B31E36E Q38068293-AC05896F-F222-4834-826D-5EA6D4877757

P2860

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

http://www.wikidata.org/entity/Q42112516

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@en

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@nl

type

label

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@en

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@nl

prefLabel

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@en

Novel mechanism of antibiotic ...... mediate Staphylococcus aureus.

@nl

P1433

Q42112516-7C8AA34C-E553-4AC9-9B15-4876594237AE

P1476

Q42112516-9609ECCC-3072-4C2C-A424-4D64522B05C5

P2093

Q42112516-2CD0ABC3-666C-41DA-A1E0-38B7E1024DE9

Q42112516-6F2A0A5D-D25C-4DB3-8A78-F5196C69512F

Q42112516-77CF5698-2F77-4FC1-B026-C4808D994711

Q42112516-A2B9375F-EF2D-41E9-8F45-FD4CBDCCB4C6

Q42112516-CD60C600-323F-4049-988E-548B0B3F1C11

Q42112516-DC8FB369-6382-4F8A-9C33-4E6809CC34B7

P2860

Q42112516-0737DB4C-776B-4DF7-8EDA-0C910B801AB6

Q42112516-21D1E231-0454-498C-BA64-F2386DA50AD4

Q42112516-226EC50C-8343-43C3-A7F0-C45297CCFFFD

Q42112516-248785C2-046E-425B-852D-7B6BFAF586E2

Q42112516-2C1F8836-1D6F-40AA-86BA-4CEE4E208B3C

Q42112516-31A126D8-174A-4A8B-943C-8734F799D447

Q42112516-333BF4C3-7D43-4290-AC7B-96C10736B940

Q42112516-37547655-F64E-444E-BD59-2B632D2226B7

Q42112516-4445E4C6-4663-475F-869A-076BC6BC7B2C

Q42112516-4A569B7E-3085-41C4-B889-3071995F7ABD

P304

Q42112516-0D5F80A1-5577-4EC9-951F-F0FAA595DFC9

P31

Q42112516-B982C411-5FA2-415B-9D6A-78BD62D87ABB

P356

Q42112516-104B1C4C-184B-4910-8146-B345C1A7976A

P407

Q42112516-D451A01C-7489-48D9-935F-69BA3844379A

P433

Q42112516-914715E0-6B61-4603-8CFD-45DCAACE3156

P478

Q42112516-1F494E08-4D55-4027-9A33-3369F81E0BEE

P50

Q42112516-4F5D0121-4019-4D89-9567-9C00B2E3BD6F

P577

Q42112516-3F33EF43-794B-4DB4-A6C7-D4D78C3B2685

P698

Q42112516-87577422-B962-4FE8-B80C-6E4367A19C73

P921

Q42112516-52013BDD-7F01-4585-8150-584954DB9AE4

P932

Q42112516-4E259CD3-6E13-4AFC-8DEC-20BBC09367FF

P356

AAC.50.2.428-438.2006

P1433

Antimicrobial Agents and Chemotherapy

P1476

Novel mechanism of antibiotic ...... rmediate Staphylococcus aureus

@en

P2093

Akira Iwamoto

http://www.w3.org/2001/XMLSchema#string

Jian-Qi Lian

http://www.w3.org/2001/XMLSchema#string

Keiichi Hiramatsu

http://www.w3.org/2001/XMLSchema#string

Longzhu Cui

http://www.w3.org/2001/XMLSchema#string

Toshiki Maruyama

http://www.w3.org/2001/XMLSchema#string

Yataro Horikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance.

DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Vancomycin-intermediate Staphylococcus aureus in Korea.

Vancomycin-resistant enterococci.

A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates

Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus.

The emergence and evolution of methicillin-resistant Staphylococcus aureus.

Oriented fragmentation of Escherichia coli sacculi by sonication.

P304

428-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.50.2.428-438.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16436693

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic resistance

P932

1366884

http://www.w3.org/2001/XMLSchema#string